He Yan-Fei
Department of Health Management Center, The Sixth Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100048, China.
World J Gastrointest Oncol. 2024 Oct 15;16(10):4289-4297. doi: 10.4251/wjgo.v16.i10.4289.
Recently, the published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
最近,[杂志名称]发表了一篇题为《多学科治疗后晚期巨大肝细胞癌病理成功转化肝切除术:病例报告及文献复习》的文章,作者在文中分享了多学科转化治疗后成功进行手术完整切除的经验。Chu的这项研究展示了晚期肝细胞癌(HCC)给外科肿瘤学带来的巨大挑战,揭示了不可切除HCC转化治疗的复杂性,强调了多学科管理模式在转化治疗中的重要作用,并丰富了我们对不同患者个体化治疗动态变化的理解。目前,转化治疗是不可切除HCC治疗中的一个热门研究话题,给许多中晚期HCC患者带来了新希望。然而,转化治疗仍有许多亟待解决的问题。在此,我们希望与作者及广大读者进一步探讨不可切除HCC转化治疗的进展与挑战。